Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1617 1658
This examiner grants 53% of resolved cases
Audrea June Buckley Coniglio has resolved 855 cases in Tech Center 1600. Her examination history in Art Unit 1611 shows an allowance rate of 52.9 percent. This figure is a primary indicator for applicants to use when evaluating the likelihood of a favorable outcome and for preparing for a potentially challenging prosecution process.
The median days to allowance for this examiner is 1197. This timeframe is essential for practitioners to consider when advising clients on the expected duration of the patenting process. A timeline of 1197 days helps in setting realistic goals for the various stages of prosecution and for budgeting legal expenses over the life of the application.
The interview lift for this examiner is 21.1 percent. This represents a significant increase over the 52.9 percent allowance rate, indicating that interviews are an effective method for resolving issues. The 21.1 percent lift suggests that practitioners should prioritize personal communication with the examiner to clarify technical disagreements and move the application toward a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18828178 | COMPOSITIONS AND RELATED METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18340949 | PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME | Final Rejection | The Procter & Gamble Company |
| 18605976 | ALKOXIDE-BASED SOLIDIFICATION USING CONCENTRATED ALKALI METAL HYDROXIDES | Final Rejection | ECOLAB USA INC. |
| 18944146 | (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP | Non-Final OA | Valent BioSciences LLC |
| 18894367 | COSMETIC COMPOSITION AND USES THEREOF | Non-Final OA | MARY KAY INC. |
| 18707260 | COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A CRYSTALLIZABLE FATTY SUBSTANCE | Non-Final OA | L'OREAL |
| 18867262 | VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER | Non-Final OA | The University of Chicago |
| 18498543 | COMPOSITIONS COMPRISING ESSENTIAL OILS | Non-Final OA | Firmenich SA |
| 17737969 | SKIN CLEANSING ARTICLE INCLUDING WATER-DISPERSIBLE AND/OR WATER-SOLUBLE CORE SUBSTRATE | Final Rejection | MONOSOL, LLC |
| 18520618 | Expandable structured dosage form for prolonged drug delivery | Non-Final OA | Dr. Aron H. Blaesi |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy